cnbc.com
Wall Street's Top Calls
Summary of Wall Street's biggest calls, including stock ratings and price target changes for various companies.
English
United States
Us PoliticsFinanceStocksMarketInvestingRatings
Morgan StanleyHome DepotBank Of AmericaCeribellLive Nation
- What is JPMorgan's outlook for Upstream Bio?
- JPMorgan initiated Upstream Bio with an overweight rating and a $38 December 2025 price target, believing the biotech company is well-positioned for success.
- What is Morgan Stanley's stance on Home Depot?
- Morgan Stanley reiterated Home Depot as overweight, citing limited downside risk and its position as a high-quality play in the macro/housing sector ahead of upcoming earnings.
- What rating did Bank of America give Ceribell and why?
- Bank of America initiated coverage of Ceribell with a buy rating and $32 price target, highlighting the company's impressive AI algorithm for neurological condition monitoring.
- What is RBC's opinion on Microsoft and its price target?
- RBC reiterated Microsoft as outperform following a visit to company headquarters, maintaining their $500 price target and constructive outlook.
- How did Morgan Stanley revise its rating and price target for Carvana?
- Morgan Stanley upgraded Carvana to equal weight from underweight, raising its price target to $260 from $110 following strong earnings that aligned with their bull case scenario.